
How La Tablee Des Chefs Is Turning Waste Into Meals
Jean-François Archambault, Founder of La Tablée des Chefs
In Canada, a paradox exists. While millions struggle to access fresh, nutritious food, perfectly good meals are discarded by restaurants, hotels, and catering companies. Food banks operate under immense strain, often lacking quality ingredients. At the same time, an invisible barrier—fear of litigation—prevents many food providers from donating surplus meals.
But where others saw an intractable problem, Jean-François Archambault saw an opportunity.
During his decade in hotel management, he wrestled with an uncomfortable truth: vast amounts of food were going to waste while communities went hungry. Reflecting on the values instilled in him through his family's community work, he knew he couldn't stand by idly. In 2004, he walked away from his career at the prestigious Fairmont Queen Elizabeth in Montreal and founded La Tablée des Chefs—a game-changing organization that connects the food industry to the fight against hunger.
'I was successful,' Archambault recalls, 'but it was like, at the end of the day, I was taking off that suit, putting it back in the closet, and then being Jean-François at home, and I hated that. I needed to wake up and feel I was whole.'
The leap wasn't easy—but it was fueled by belief and mentorship. 'That sense of purpose came to me very strongly when I met my wife—and she gave me confidence,' he shares. 'Having her by my side and believing in me really helped. And then some key business people, one in particular who became a mentor—she was the Executive VP of HR at National Bank of Canada—really pushed me to do something.'
He recalls preparing to hire La Tablée's first employee after raising $150,000, only to have a moment of clarity over breakfast with his mentor. 'I told her I stopped the hiring process,' he says. 'She asked why, and I said, 'Because I'm going to do it. Nobody else is better than me to do that.' That's where it all started.'
Archambault's first challenge was to dismantle a system built on fear. Working alongside legal experts, he uncovered an overlooked solution: Good Samaritan laws. These laws protect food providers from liability when donating food in good faith. By educating businesses and industry leaders on these protections, he flipped the script, shifting mindsets from risk aversion to social impact.
In provinces like Alberta, vague food safety regulations still prevent large quantities of safe, untouched food from being recovered. Archambault is working with pro bono legal partners to change that. 'We could double the amount of food that we recover if we clarify the definition of served food,' he says.
Next, he forged powerful partnerships with industry heavyweights, such as Montreal's Bell Centre, home to the Canadiens hockey team. His vision: a streamlined system where surplus food is retrieved, repurposed, and distributed to those in need—at scale.
'What I really want to do is change the mindset of the industry on looking at food waste—and looking at food that can be recovered that is not recovered,' he says. 'To really engage in maximizing all the opportunities we have as an industry. I'm talking about the hospitality industry coming together to prioritize this—and getting the industry around to change.'
He emphasizes that many workers in the industry already want to help—they've simply lacked a system that makes it possible. 'The industry is not aware that a lot of hotel and convention spaces employees are all for this,' Archambault says. 'But they've been stopping to think it's possible. And I'm here to make that possible.'
A key milestone came when Marriott Canada stepped up. 'When we signed the agreement with Marriott Canada, the president at the time said, 'I want this in my 260 hotels,'' Archambault recalls. That really helped accelerate the change. Thanks to that kind of leadership, word spread quickly within the industry.
Through these partnerships, La Tablée des Chefs has built an operational backbone that makes food recovery seamless for hospitality teams. Using a data-driven platform, the organization coordinates surplus food collection and meal distribution with precision. Restaurants, hotels, and caterers donate prepared meals, which are then labeled, packaged, and delivered to food banks and shelters based on real-time demand. The result? A sustainable, systemic solution to food insecurity—one that empowers the industry to act with both efficiency and compassion.
'We have 400 hotels or venues doing this across the country and serving 3 million meals annually,' he explains.
La Tablée des Chefs—a game-changing organization that connects the food industry to the fight ... More against hunger
But Archambault knew that simply providing meals wasn't enough. To truly address food insecurity, he needed to empower communities to feed themselves.
Enter La Tablée des Chefs' culinary training programs. Through initiatives like Kitchen Brigades and Cook Up Your Future, the organization is teaching vulnerable youth how to prepare high-quality, low-cost meals—building self-sufficiency where it's needed most. From schools and youth centers to juvenile detention facilities, their culinary education initiatives are equipping young people with essential life skills—and a pathway to a brighter future.
'We're in more than 350 public high schools with chefs coming into schools every day,' says Archambault. 'We've educated over 75,000 youth through food education and food literacy.'
In 2018, the Quebec government made a major investment in the program, allowing it to scale even further. La Tablée des Chefs now runs an e-learning platform and a culinary school, ensuring that its impact reaches far beyond the kitchen.
La Tablée des Chefs' culinary training programs
In its first 15 years, La Tablée des Chefs has provided over 20 million meals to food-insecure communities, partnered with more than 400 hotels and venues across Canada, and trained young people in more than 350 public high schools and foster care programs across seven provinces. But Archambault's ambition doesn't stop at Canada's borders.
Today, the model is being tested in France, with plans to expand into culinary schools across Canada. By fostering a new generation of socially conscious chefs, La Tablée des Chefs is proving that food is more than just sustenance—it's a vehicle for social change.
That impact was powerfully demonstrated at the President's Cup PGA tournament at the Royal Montreal Golf Club.'There were 30 small kitchens on the course feeding tens of thousands of people,' Archambault recalls. 'We partnered with Proof of the Pudding, the PGA's caterer, and recovered 22 tons of food that fed over 120,000 people in six days.'
The quality of the food, he says, is often what surprises people most.'We opened one aluminum container, and it was these lamb chops—pink, perfect,' he says. 'Would you eat that tomorrow? Absolutely. That's the kind of dignity this brings.'
In its first 15 years, La Tablée des Chefs has provided over 20 million meals to food-insecure ... More communities.
Jean-François Archambault's work isn't just about feeding people—it's about transforming the way we think about food. It's about reimagining a food system where waste is no longer the norm, where chefs wield their expertise as a force for good, and where communities are empowered to take control of their own nutrition.
'We are the missing link into making that food accessible to the front line,' he says. 'And that's really what I want to continue to do.'
This is what happens when passion meets purpose. And this is how one man—and a growing movement of compassionate chefs and business leaders—are rewriting the future of food in Canada and beyond.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
9 hours ago
- Yahoo
BNP Paribas to shutter 200 branches in France by 2027
BNP Paribas is reportedly planning to reduce its network of retail branches in France as part of a strategy to enhance profitability. Its CEO Jean-Laurent Bonnafe confirmed that the bank intends to close approximately 80 branches this year, followed by an additional 120 in the next year, reported Bloomberg. Reports from French newspaper Les Echos suggest that the total number of branch closures could reach approximately 500 by 2030. This move is expected to lead to a 5% annual reduction in branch staff, while the bank aims to increase employment in online and telephone banking services. Discussions with labour unions regarding this strategy, which was first communicated in March, are ongoing. Sources familiar with the situation indicated that impacted staff will be offered alternative roles within the organisation. Besides, BNP Paribas is relying on natural attrition to manage workforce reductions without resorting to layoffs. A spokesperson for BNP Paribas stated: 'We presented in March an ambitious growth plan to trade unions that outlines a strategic roadmap and related investments for our Commercial & Personal Banking in France. Every employee of the bank has their place in this project.' The restructuring is part of Bonnafe's focus on revitalising the retail banking sector, which has faced challenges due to local regulations and the European Central Bank's monetary policies. Isabelle Loc, who was appointed to lead the retail banking division following the departure of Marguerite Berard, is expected to leverage the digital platform Hello bank and private banking services to drive growth. The bank currently operates around 1,500 branches in France, and under Loc's strategy, some branch functions will be shifted to remote customer service centres, with employees being offered new positions. BNP Paribas plans to reveal further details about its restructuring strategy by the end of June. In April this year, BNP Paribas extended its partnership with IBM Cloud for another ten years to enhance its cloud-native strategy and advance generative artificial intelligence (GenAI) capabilities. "BNP Paribas to shutter 200 branches in France by 2027" was originally created and published by Retail Banker International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
10 hours ago
- Yahoo
Keros Announces Return of $375 Million in Excess Capital to Stockholders
Concludes Strategic Alternatives Review and Provides Update on Development of KER-065 LEXINGTON, Mass., June 09, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ('Keros' or the 'Company') (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta ('TGF-ß') family of proteins, today announced that the Company has concluded its previously announced review process to evaluate strategic alternatives to maximize stockholder value for the Company. As a result of this process, the Company's Board of Directors (the 'Board') unanimously determined to initiate a process to return $375 million of excess capital to stockholders. The terms and structure of this capital return remain under consideration and are expected to be announced at a future date. Jean-Jacques Bienaimé, Lead Independent Director, said, 'Our Board and management team are taking action to enhance stockholder value. To that end, we intend to return a significant amount of excess capital to stockholders while continuing to pursue development of our lead product candidate, KER-065, for the treatment of neuromuscular diseases, with an initial focus on Duchenne muscular dystrophy. This reflects a thorough review of our capital requirements, feedback from our stockholders, and our confidence in the potential for Keros to provide meaningful and potentially disease-modifying benefits to patients.' During the strategic review process, the Board, with the assistance of the strategic committee of the Board and outside financial and legal advisors, evaluated a comprehensive range of strategic alternatives, including but not limited to a sale of the Company or other business combination transaction, continued investment in the Company's pipeline, and/or return of excess capital to stockholders. The evaluation of these alternatives involved outreach to a number of third parties and engagement with Company stockholders. This press release is not an offer to sell or a solicitation of an offer to buy any of the Company's securities. About Keros Therapeutics, Inc. Keros is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the TGF-ß family of proteins. Keros is a leader in understanding the role of the TGF-ß family of proteins, which are master regulators of the growth, repair and maintenance of a number of tissues, including blood, bone, skeletal muscle, adipose and heart tissue. By leveraging this understanding, Keros has discovered and is developing protein therapeutics that have the potential to provide meaningful and potentially disease-modifying benefit to patients. Keros' lead product candidate, KER-065, is being developed for the treatment of neuromuscular diseases, with an initial focus on Duchenne muscular dystrophy. Keros' most advanced product candidate, elritercept (KER-050), is being developed for the treatment of cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndrome and in patients with myelofibrosis. Cautionary Note Regarding Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Words such as 'anticipates,' 'believes,' 'continue,' 'expects,' 'enable,' 'intention,' 'potential' and 'will' or similar expressions are intended to identify forward-looking statements. Examples of these forward-looking statements include statements concerning the intention, terms, structure and timing of return of excess capital by the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among others: the terms and structure of the capital return; the timing of the capital return; the risk that the capital return could have an adverse effect on the ability of the Company to retain and hire key personnel and maintain relationships with partners, suppliers, employees, stockholders and other business relationships and on its operating results and business generally; the risk of any litigation relating to the strategic review; Keros' limited operating history and historical losses; Keros' ability to raise additional funding to complete the development and any commercialization of its product candidates; Keros' dependence on the success of its product candidates, KER-065 and elritercept; that Keros may be delayed in initiating, enrolling or completing any clinical trials; competition from third parties that are developing products for similar uses; Keros' ability to obtain, maintain and protect its intellectual property; and Keros' dependence on third parties in connection with manufacturing, clinical trials and preclinical studies. These and other risks are described more fully in Keros' filings with the Securities and Exchange Commission (the 'SEC'), including the 'Risk Factors' section of the Company's Quarterly Report on Form 10-Q, filed with the SEC on May 6, 2025, and its other documents subsequently filed with or furnished to the SEC. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except to the extent required by law, Keros undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made. Contacts Investor Contact:Justin Frantzjfrantz@ Media Contact:Mahmoud Siddig / Adam Pollack / Viveca TressJoele Frank, Wilkinson Brimmer Katcher(212) 355-4449Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
Chesapeake Gold Announces $4.4 Million Non-Brokered Private Placement with Eric Sprott
Vancouver, British Columbia--(Newsfile Corp. - June 9, 2025) - Chesapeake Gold Corp. (TSXV: CKG) (OTCQX: CHPGF) ("Chesapeake" or the "Company") is pleased to announce a non-brokered private placement of 3,700,000 units ("Units") at a price of $1.20 per Unit for gross proceeds of $4,440,000 (the "Private Placement"). Each Unit will consist of one common share of the Company and one-half common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will be exercisable for one common share of the Company at a price of $1.65 for a period of three years from the date of issuance. 2176423 Ontario Ltd., a Corporation beneficially owned by Eric Sprott, is the sole subscriber in the Private Placement. After completion of the Private Placement, Eric Sprott will beneficially own and control 12,883,499 Common Shares, and 1,850,000 Warrants representing approximately 17.9% of the outstanding Common Shares on a non-diluted basis and 19.9% of the outstanding Common Shares on a partially diluted basis assuming exercise of such Warrants. Jean-Paul Tsotsos, Interim Chief Executive Officer, commented, "We are pleased to see Eric Sprott increase his investment in Chesapeake. His longstanding support reflects confidence in our strategic objectives and vision. The financing will be instrumental in accelerating the testing of our proprietary leach technology on Metates and soon other project opportunities. We are excited that the coming year will unlock significant shareholder value supported by delivering key milestones." The net proceeds of the Private Placement will be used to advance the Company's proprietary oxidative leach technology, ongoing exploration, including the Lucy project, and for general working capital. There are no finder's fees or other commissions associated with the Private Placement. The Private Placement is subject to the receipt of all necessary approvals, including the approval of the TSX Venture Exchange. The Units issued under the Private Placement will be subject to a hold period under applicable Canadian securities laws until four months and one day after the closing of the Private Placement. The securities described in this news release have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any applicable securities laws of any state of the United States, and may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons (as such term is defined in Regulation S under the U.S. Securities Act) or persons in the United States unless registered under the U.S. Securities Act and any other applicable securities laws of the United States or an exemption from such registration requirements is available. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of these securities within any jurisdiction, including the United States. The Private Placement involves a "related party transaction" within the meaning of TSX Venture Exchange Policy 5.9 (the "Policy") and Multilateral Instrument 61-101-Protection of Minority Security Holders in Special Transactions ("MI 61-101") adopted in the Policy. The Company intends to rely on exemptions from the formal valuation and minority shareholder approval requirements of MI 61-101 contained in sections 5.5(a) and 5.7(1)(a) of MI 61-101 in respect of related party participation in the Private Placement as neither the fair market value (as determined under MI 61-101) of the subject matter of, nor the fair market value of the consideration for, the transaction is expected to exceed 25% of the Company's market capitalization (as determined under MI 61-101). For Further Information: For more information on Chesapeake, its Metates and Lucy Projects or proprietary oxidative leach technology, please visit our website at or contact Jean-Paul Tsotsos at invest@ or +1 778 731 1362. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release. About Chesapeake Chesapeake Gold Corp's flagship asset is the Metates Project ("Metates") located in Durango State, Mexico. Metates hosts one of the largest undeveloped gold-silver deposits in the Americas1 with over 16.77 million ounces of gold at 0.57 grams per tonne (g/t) and 423.2 million ounces of silver at 14.3 g/t within 921.2 million tonnes in the Measured and Indicated Mineral Resource category and a further 2.13 million ounces of gold at 0.47 g/t and 59.0 million ounces of silver at 13.2 g/t within 139.5 million tonnes in the Inferred Mineral Resource category. See the technical report titled "Metates Sulphide Heap Leach Project Phase I" dated January 13, 2023, and news release dated February 22, 2023. Forward-looking Statements This news release contains "forward-looking information" which may include, but is not limited to, statements with respect to completion of the Private Placement and use of proceeds of the Private Placement. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and are based on various assumptions. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Such factors include, among others, the receipt of applicable regulatory approvals; closing of the Private Placement; timing and content of work programs; results of exploration activities; results from the Company's proprietary oxidative leach technology; general business, economic, competitive, political and social uncertainties; changes in project parameters as plans continue to be refined; accidents, labour disputes and other risks of the mining industry, and political instability. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements contained herein are made as of the date of this news release and the Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or results, except as may be required by applicable securities laws. There can be no assurance that forward-looking statements will prove to be accurate as actual results and future events could differ materially from those anticipated in such statements. 1 Mexico's biggest undeveloped gold deposits. Bnamericas. Published Tuesday, November 24, 2020. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data